Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction - Trial NCT05920629
Access comprehensive clinical trial information for NCT05920629 through Pure Global AI's free database. This phase not specified trial is sponsored by Baris Gencer and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 220 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Baris Gencer
University Hospital, Geneva
Timeline & Enrollment
N/A
Jun 01, 2023
Apr 30, 2026
Primary Outcome
Cardiac function
Summary
A total of 220 patients (110 per arm) who report moderate alcohol consumption between 4 and
 28 standard units (1 standard unit = ~10 grams) per week in the 12 months prior to hospital
 admission will be planned for randomization, using a 1:1 ratio to pursue moderate alcohol
 consumption (1 standard unit per day for women and 2 standard units per day for men for 12
 months) or abstinence (except for one drink on predefined/agreed special occasions) for a
 total duration of 12 months. An echocardiography will be performed at baseline and 12 months
 to assess changes in systolic cardiac function (LVEF) for the primary endpoint. A core
 laboratory team blinded to assignment will perform data interpretation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05920629
Non-Device Trial